Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schenone

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Pharmaceutical Design|July 14, 2007
SRC inhibitors and angiogenesisS Schenone, F Manetti, M Botta
Mini Reviews in Medicinal Chemistry|February 20, 2007
Last findings on dual inhibitors of abl and SRC tyrosine-kinasesS Schenone, F Manetti, M Botta
Current Medicinal Chemistry|February 20, 2010
New opportunities to treat the T315I-Bcr-Abl mutant in chronic myeloid leukaemia: tyrosine kinase inhibitors and molecules that act by alternative mechanismsS Schenone, C Brullo, M Botta
Current Medicinal Chemistry|December 17, 2008
Small molecules ATP-competitive inhibitors of FLT3: a chemical overviewS Schenone, C Brullo, M Botta
Current Medicinal Chemistry|November 6, 2007
Antiangiogenic agents: an update on small molecule VEGFR inhibitorsS Schenone, F Bondavalli, M Botta
Boletin Chileno De Parasitologia|January 1, 1992
[Oral elimination of strobila segments of Taenia saginata]H Schenone, S Schenone, J Arriagada
Medicinal Research Reviews|August 29, 2009
New insights into small-molecule inhibitors of Bcr-AblS Schenone, O Bruno, M Radi, et al.
Current Medicinal Chemistry|June 10, 2011
ATP-competitive inhibitors of mTOR: an updateS Schenone, C Brullo, F Musumeci, et al.
Current Medicinal Chemistry|November 5, 2011
SRC kinase inhibitors: an update on patented compoundsS Schenone, C Brullo, F Musumeci, et al.
Current Topics in Medicinal Chemistry|April 8, 2010
A1 receptors ligands: past, present and future trendsS Schenone, C Brullo, F Musumeci, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Pharmaceutical Design|July 14, 2007
SRC inhibitors and angiogenesisS Schenone, F Manetti, M Botta
Mini Reviews in Medicinal Chemistry|February 20, 2007
Last findings on dual inhibitors of abl and SRC tyrosine-kinasesS Schenone, F Manetti, M Botta
Current Medicinal Chemistry|February 20, 2010
New opportunities to treat the T315I-Bcr-Abl mutant in chronic myeloid leukaemia: tyrosine kinase inhibitors and molecules that act by alternative mechanismsS Schenone, C Brullo, M Botta
Current Medicinal Chemistry|December 17, 2008
Small molecules ATP-competitive inhibitors of FLT3: a chemical overviewS Schenone, C Brullo, M Botta
Current Medicinal Chemistry|November 6, 2007
Antiangiogenic agents: an update on small molecule VEGFR inhibitorsS Schenone, F Bondavalli, M Botta
Boletin Chileno De Parasitologia|January 1, 1992
[Oral elimination of strobila segments of Taenia saginata]H Schenone, S Schenone, J Arriagada
Medicinal Research Reviews|August 29, 2009
New insights into small-molecule inhibitors of Bcr-AblS Schenone, O Bruno, M Radi, et al.
Current Medicinal Chemistry|June 10, 2011
ATP-competitive inhibitors of mTOR: an updateS Schenone, C Brullo, F Musumeci, et al.
Current Medicinal Chemistry|November 5, 2011
SRC kinase inhibitors: an update on patented compoundsS Schenone, C Brullo, F Musumeci, et al.
Current Topics in Medicinal Chemistry|April 8, 2010
A1 receptors ligands: past, present and future trendsS Schenone, C Brullo, F Musumeci, et al.
Pageof 5